Literature DB >> 19806663

Venous thrombosis associated with gene deletion of tissue factor pathway inhibitor.

Alex Kentsis, Gary Bradwin, David T Miller, Cameron C Trenor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19806663      PMCID： PMC4659489          DOI： 10.1002/ajh.21542

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

1.  The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1.

Authors:  A E A Dahm; P M Sandset; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2007-11-27       Impact factor: 5.824

2.  The del(2)(q32.2q33) deletion syndrome defined by clinical and molecular characterization of four patients.

Authors:  G Van Buggenhout; C Van Ravenswaaij-Arts; N Mc Maas; R Thoelen; A Vogels; Dominique Smeets; I Salden; G Matthijs; J-P Fryns; J R Vermeesch
Journal:  Eur J Med Genet       Date:  2005 Jul-Sep       Impact factor: 2.708

3.  Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden.

Authors:  Daniel T Eitzman; Randal J Westrick; Xiaoming Bi; Sara L Manning; John E Wilkinson; George J Broze; David Ginsburg
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

4.  Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.

Authors:  Z F Huang; D Higuchi; N Lasky; G J Broze
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

Review 5.  The haemostatic role of tissue factor pathway inhibitor.

Authors:  James T B Crawley; David A Lane
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-10-19       Impact factor: 8.311

6.  Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.

Authors:  Tilman M Hackeng; Kristin M Seré; Guido Tans; Jan Rosing
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

7.  Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis.

Authors:  Anders Dahm; Astrid Van Hylckama Vlieg; Bjorn Bendz; Frits Rosendaal; Rogier M Bertina; Per Morten Sandset
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113
  7 in total
  1 in total

1.  Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation.

Authors:  Shigeo Horinaka; Rie Sugawara; Yutaka Yonezawa; Toshihiko Ishimitsu
Journal:  Br J Clin Pharmacol       Date:  2017-10-18       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.